Skip to main content
Equibles

LEVEL FOUR ADVISORY SERVICES, LLC

Position in TVTX — Travere Therapeutics, Inc.

CIK 1696715 DALLAS, TX
Back to TVTX Full portfolio

Position in TVTX

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$312,795
+$108,143 QoQ
Shares Held
5,506
+2.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#235
of 319 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TVTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LEVEL FOUR ADVISORY SERVICES, LLC holds $9,160,165 across 9 Biotechnology names. TVTX ranks #5 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 10,034 $4,984,188
2 GMAB
Genmab A/S
 58,000 $1,593,260
3 ARGX
Argenx SE
 1,148 $1,065,079
4 JAZZ
Jazz Pharmaceuticals plc
 3,490 $840,985
5 TVTX
Travere Therapeutics, Inc.
This page 		5,506 $312,795
6 REGN
Regeneron Pharmaceuticals, Inc.
 396 $246,921
7 MNKD
Mannkind Corp
 21,338 $90,899
8 OCGN
Ocugen, Inc.
 17,000 $26,010

All Filings in TVTX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $312,795 5,506
2025-12-31 $204,652 5,356